Details for New Drug Application (NDA): 021119
✉ Email this page to a colleague
NDA 021119 describes VISUDYNE, which is a drug marketed by Bausch Lomb Ireland and is included in one NDA. It is available from two suppliers. Additional details are available on the VISUDYNE profile page.
The generic ingredient in VISUDYNE is verteporfin. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the verteporfin profile page.
The generic ingredient in VISUDYNE is verteporfin. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the verteporfin profile page.
Summary for 021119
| Tradename: | VISUDYNE |
| Applicant: | Bausch Lomb Ireland |
| Ingredient: | verteporfin |
| Patents: | 0 |
Pharmacology for NDA: 021119
| Mechanism of Action | Photoabsorption |
| Physiological Effect | Photosensitizing Activity |
Suppliers and Packaging for NDA: 021119
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119 | NDA | Bausch Health US LLC | 0187-5600 | 0187-5600-15 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0187-5600-15) |
| VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119 | NDA | Bausch & Lomb Incorporated | 24208-560 | 24208-560-15 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (24208-560-15) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/VIAL | ||||
| Approval Date: | Apr 12, 2000 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 021119
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,707,608 | ⤷ Get Started Free |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 4,833,790 | ⤷ Get Started Free |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,756,541 | ⤷ Get Started Free |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,770,619 | ⤷ Get Started Free |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,283,255 | ⤷ Get Started Free |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,095,030 | ⤷ Get Started Free |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,798,349 | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
